APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sterile Injectable CDMO

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sterile Injectable CDMO Industry Growth and Trends Forecast to 2032

30 January 2026123 pages

Choose your research edition.

Industry ResearchSterile Injectable CDMO Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Sterile Injectable CDMO Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Sterile Injectable CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sterile Injectable CDMO Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Sterile Injectable CDMO Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

According to APO Research, the global Sterile Injectable CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sterile Injectable CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sterile Injectable CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sterile Injectable CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Sterile Injectable CDMO market include Abbvie, Famar, Polfa Tarchomin, Pfizer, Quotient Sciences, Temad Co., Tianjin Hankang Pharmaceutical Biotechnology, Fareva and Sharp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sterile Injectable CDMO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sterile Injectable CDMO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sterile Injectable CDMO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sterile Injectable CDMO.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Sterile Injectable CDMO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sterile Injectable CDMO Market by Company

Abbvie

Famar

Polfa Tarchomin

Pfizer

Quotient Sciences

Temad Co.

Tianjin Hankang Pharmaceutical Biotechnology

Fareva

Sharp

Astral SteriTech

Evonik

Aurigene Pharmaceutical Services

Prague Scientific

Ethypharm

TriRx Pharmaceutical Services

Biophrama Group

Gensenta Pharmaceuticals

BioTechnique

Mithra CDMo

S.C. Rompharm Company SRL

Flagship Biotech International Pvt. Ltd

Curida AS

BirgiMefar Group

Brooks Laboratories Limited

Sterile Injectable CDMO Segment by Type

Preclinical Manufacturing

Clinical Manufacturing

Commercial Manufacturing

Sterile Injectable CDMO Segment by Application

Pharmaceutical Company

Research Institute

Other

Sterile Injectable CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sterile Injectable CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sterile Injectable CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sterile Injectable CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Sterile Injectable CDMO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Sterile Injectable CDMO Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Sterile Injectable CDMO Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Sterile Injectable CDMO Market Share by Region (2021-2026) Table 4. Global Sterile Injectable CDMO Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Sterile Injectable CDMO Market Share by Region (2027-2032) Table 6. Global Sterile Injectable CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Sterile Injectable CDMO Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Sterile Injectable CDMO Market Size Share by Type (2021-2026) Table 9. Global Sterile Injectable CDMO Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Sterile Injectable CDMO Market Size Share Forecasted by Type (2027-2032) Table 11. North America Sterile Injectable CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Sterile Injectable CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Sterile Injectable CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Sterile Injectable CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Sterile Injectable CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Sterile Injectable CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Sterile Injectable CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Sterile Injectable CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Sterile Injectable CDMO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Sterile Injectable CDMO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Sterile Injectable CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Sterile Injectable CDMO Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Sterile Injectable CDMO Market Size Share by Application (2021-2026) Table 24. Global Sterile Injectable CDMO Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Sterile Injectable CDMO Market Size Share Forecasted by Application (2027-2032) Table 26. North America Sterile Injectable CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Sterile Injectable CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Sterile Injectable CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Sterile Injectable CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Sterile Injectable CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Sterile Injectable CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Sterile Injectable CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Sterile Injectable CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Sterile Injectable CDMO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Sterile Injectable CDMO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Sterile Injectable CDMO Industry Trends Table 37. Sterile Injectable CDMO Industry Drivers Table 38. Sterile Injectable CDMO Industry Opportunities and Challenges Table 39. Sterile Injectable CDMO Industry Restraints Table 40. Global Sterile Injectable CDMO Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Sterile Injectable CDMO Revenue Market Share by Company (2021-2026) Table 42. Global Sterile Injectable CDMO Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Sterile Injectable CDMO Key Company Headquarters & Area Served Table 44. Global Sterile Injectable CDMO Company, Product Type & Application Table 45. Global Sterile Injectable CDMO Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Sterile Injectable CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbvie Company Information Table 49. Abbvie Business Overview Table 50. Abbvie Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbvie Sterile Injectable CDMO Product Portfolio Table 52. Abbvie Recent Development Table 53. Famar Company Information Table 54. Famar Business Overview Table 55. Famar Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Famar Sterile Injectable CDMO Product Portfolio Table 57. Famar Recent Development Table 58. Polfa Tarchomin Company Information Table 59. Polfa Tarchomin Business Overview Table 60. Polfa Tarchomin Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Polfa Tarchomin Sterile Injectable CDMO Product Portfolio Table 62. Polfa Tarchomin Recent Development Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer Sterile Injectable CDMO Product Portfolio Table 67. Pfizer Recent Development Table 68. Quotient Sciences Company Information Table 69. Quotient Sciences Business Overview Table 70. Quotient Sciences Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Quotient Sciences Sterile Injectable CDMO Product Portfolio Table 72. Quotient Sciences Recent Development Table 73. Temad Co. Company Information Table 74. Temad Co. Business Overview Table 75. Temad Co. Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Temad Co. Sterile Injectable CDMO Product Portfolio Table 77. Temad Co. Recent Development Table 78. Tianjin Hankang Pharmaceutical Biotechnology Company Information Table 79. Tianjin Hankang Pharmaceutical Biotechnology Business Overview Table 80. Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Product Portfolio Table 82. Tianjin Hankang Pharmaceutical Biotechnology Recent Development Table 83. Fareva Company Information Table 84. Fareva Business Overview Table 85. Fareva Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Fareva Sterile Injectable CDMO Product Portfolio Table 87. Fareva Recent Development Table 88. Sharp Company Information Table 89. Sharp Business Overview Table 90. Sharp Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sharp Sterile Injectable CDMO Product Portfolio Table 92. Sharp Recent Development Table 93. Astral SteriTech Company Information Table 94. Astral SteriTech Business Overview Table 95. Astral SteriTech Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Astral SteriTech Sterile Injectable CDMO Product Portfolio Table 97. Astral SteriTech Recent Development Table 98. Evonik Company Information Table 99. Evonik Business Overview Table 100. Evonik Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Evonik Sterile Injectable CDMO Product Portfolio Table 102. Evonik Recent Development Table 103. Aurigene Pharmaceutical Services Company Information Table 104. Aurigene Pharmaceutical Services Business Overview Table 105. Aurigene Pharmaceutical Services Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Aurigene Pharmaceutical Services Sterile Injectable CDMO Product Portfolio Table 107. Aurigene Pharmaceutical Services Recent Development Table 108. Prague Scientific Company Information Table 109. Prague Scientific Business Overview Table 110. Prague Scientific Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Prague Scientific Sterile Injectable CDMO Product Portfolio Table 112. Prague Scientific Recent Development Table 113. Ethypharm Company Information Table 114. Ethypharm Business Overview Table 115. Ethypharm Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Ethypharm Sterile Injectable CDMO Product Portfolio Table 117. Ethypharm Recent Development Table 118. TriRx Pharmaceutical Services Company Information Table 119. TriRx Pharmaceutical Services Business Overview Table 120. TriRx Pharmaceutical Services Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. TriRx Pharmaceutical Services Sterile Injectable CDMO Product Portfolio Table 122. TriRx Pharmaceutical Services Recent Development Table 123. Biophrama Group Company Information Table 124. Biophrama Group Business Overview Table 125. Biophrama Group Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Biophrama Group Sterile Injectable CDMO Product Portfolio Table 127. Biophrama Group Recent Development Table 128. Gensenta Pharmaceuticals Company Information Table 129. Gensenta Pharmaceuticals Business Overview Table 130. Gensenta Pharmaceuticals Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Gensenta Pharmaceuticals Sterile Injectable CDMO Product Portfolio Table 132. Gensenta Pharmaceuticals Recent Development Table 133. BioTechnique Company Information Table 134. BioTechnique Business Overview Table 135. BioTechnique Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. BioTechnique Sterile Injectable CDMO Product Portfolio Table 137. BioTechnique Recent Development Table 138. Mithra CDMo Company Information Table 139. Mithra CDMo Business Overview Table 140. Mithra CDMo Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Mithra CDMo Sterile Injectable CDMO Product Portfolio Table 142. Mithra CDMo Recent Development Table 143. S.C. Rompharm Company SRL Company Information Table 144. S.C. Rompharm Company SRL Business Overview Table 145. S.C. Rompharm Company SRL Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. S.C. Rompharm Company SRL Sterile Injectable CDMO Product Portfolio Table 147. S.C. Rompharm Company SRL Recent Development Table 148. Flagship Biotech International Pvt. Ltd Company Information Table 149. Flagship Biotech International Pvt. Ltd Business Overview Table 150. Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Product Portfolio Table 152. Flagship Biotech International Pvt. Ltd Recent Development Table 153. Curida AS Company Information Table 154. Curida AS Business Overview Table 155. Curida AS Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Curida AS Sterile Injectable CDMO Product Portfolio Table 157. Curida AS Recent Development Table 158. BirgiMefar Group Company Information Table 159. BirgiMefar Group Business Overview Table 160. BirgiMefar Group Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. BirgiMefar Group Sterile Injectable CDMO Product Portfolio Table 162. BirgiMefar Group Recent Development Table 163. Brooks Laboratories Limited Company Information Table 164. Brooks Laboratories Limited Business Overview Table 165. Brooks Laboratories Limited Sterile Injectable CDMO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Brooks Laboratories Limited Sterile Injectable CDMO Product Portfolio Table 167. Brooks Laboratories Limited Recent Development Table 168. North America Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. North America Sterile Injectable CDMO Market Size by Country (2021-2026) & (US$ Million) Table 170. North America Sterile Injectable CDMO Market Share by Country (2021-2026) Table 171. North America Sterile Injectable CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. North America Sterile Injectable CDMO Market Share Forecast by Country (2027-2032) Table 173. Europe Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Europe Sterile Injectable CDMO Market Size by Country (2021-2026) & (US$ Million) Table 175. Europe Sterile Injectable CDMO Market Share by Country (2021-2026) Table 176. Europe Sterile Injectable CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Europe Sterile Injectable CDMO Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Sterile Injectable CDMO Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Sterile Injectable CDMO Market Share by Country (2021-2026) Table 181. Asia-Pacific Sterile Injectable CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Sterile Injectable CDMO Market Share Forecast by Country (2027-2032) Table 183. Latin America Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Sterile Injectable CDMO Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Sterile Injectable CDMO Market Share by Country (2021-2026) Table 186. Latin America Sterile Injectable CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Sterile Injectable CDMO Market Share Forecast by Country (2027-2032) Table 188. Middle East & Africa Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East & Africa Sterile Injectable CDMO Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East & Africa Sterile Injectable CDMO Market Share by Country (2021-2026) Table 191. Middle East & Africa Sterile Injectable CDMO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East & Africa Sterile Injectable CDMO Market Share Forecast by Country (2027-2032) Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Sterile Injectable CDMO Product Image Figure 3. Global Sterile Injectable CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Sterile Injectable CDMO Market Size (2021-2032) & (US$ Million) Figure 5. Global Sterile Injectable CDMO Market Share by Region: 2025 VS 2032 Figure 6. Global Sterile Injectable CDMO Market Share by Region (2021-2032) Figure 7. North America Sterile Injectable CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Sterile Injectable CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Sterile Injectable CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Sterile Injectable CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Sterile Injectable CDMO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Preclinical Manufacturing Image Figure 13. Global Preclinical Manufacturing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Clinical Manufacturing Image Figure 15. Global Clinical Manufacturing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Commercial Manufacturing Image Figure 17. Global Commercial Manufacturing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Sterile Injectable CDMO Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Sterile Injectable CDMO Market Share by Type 2025 VS 2032 Figure 20. North America Sterile Injectable CDMO Market Size Share by Type (2021-2032) Figure 21. Europe Sterile Injectable CDMO Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Sterile Injectable CDMO Market Size Share by Type (2021-2032) Figure 23. Latin America Sterile Injectable CDMO Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Sterile Injectable CDMO Market Size Share by Type (2021-2032) Figure 25. Pharmaceutical Company Image Figure 26. Global Pharmaceutical Company Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Research Institute Image Figure 28. Global Research Institute Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Sterile Injectable CDMO Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Sterile Injectable CDMO Market Share by Application 2025 VS 2032 Figure 33. North America Sterile Injectable CDMO Market Size Share by Application (2021-2032) Figure 34. Europe Sterile Injectable CDMO Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Sterile Injectable CDMO Market Size Share by Application (2021-2032) Figure 36. Latin America Sterile Injectable CDMO Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Sterile Injectable CDMO Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Sterile Injectable CDMO Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Sterile Injectable CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Sterile Injectable CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Sterile Injectable CDMO Market Share by Country (2021-2032) Figure 43. Europe Sterile Injectable CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Sterile Injectable CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sterile Injectable CDMO Market Share by Country (2021-2032) Figure 46. Asia-Pacific Sterile Injectable CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Sterile Injectable CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Sterile Injectable CDMO Market Share by Country (2021-2032) Figure 49. Latin America Sterile Injectable CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Sterile Injectable CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Sterile Injectable CDMO Market Share by Country (2021-2032) Figure 52. Middle East & Africa Sterile Injectable CDMO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Sterile Injectable CDMO Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Sterile Injectable CDMO Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical Manufacturing
  • Clinical Manufacturing
  • Commercial Manufacturing
Applications
  • Pharmaceutical Company
  • Research Institute
  • Other
Companies covered
  • Abbvie
  • Famar
  • Polfa Tarchomin
  • Pfizer
  • Quotient Sciences
  • Temad Co.
  • Tianjin Hankang Pharmaceutical Biotechnology
  • Fareva
  • Sharp
  • Astral SteriTech
  • Evonik
  • Aurigene Pharmaceutical Services
  • Prague Scientific
  • Ethypharm
  • TriRx Pharmaceutical Services
  • Biophrama Group
  • Gensenta Pharmaceuticals
  • BioTechnique
  • Mithra CDMo
  • S.C. Rompharm Company SRL
  • Flagship Biotech International Pvt. Ltd
  • Curida AS
  • BirgiMefar Group
  • Brooks Laboratories Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Sterile Injectable CDMO Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Sterile Injectable CDMO Market Size by Region (2021-2032)
  5. 1.4.1 Global Sterile Injectable CDMO Market Size by Region (2021-2026)
  6. 1.4.2 Global Sterile Injectable CDMO Market Size by Region (2027-2032)
  7. 1.5 Key Regions Sterile Injectable CDMO Market Size (2021-2032)
  8. 1.5.1 North America Sterile Injectable CDMO Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Sterile Injectable CDMO Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Sterile Injectable CDMO Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Sterile Injectable CDMO Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Sterile Injectable CDMO Market Size Growth Rate (2021-2032)
2 Sterile Injectable CDMO Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Preclinical Manufacturing
  3. 2.1.2 Clinical Manufacturing
  4. 2.1.3 Commercial Manufacturing
  5. 2.2 Global Sterile Injectable CDMO Market Size by Type
  6. 2.2.1 Global Sterile Injectable CDMO Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Sterile Injectable CDMO Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Sterile Injectable CDMO Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Sterile Injectable CDMO Market Size by Regions
  10. 2.3.1 North America Sterile Injectable CDMO Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Sterile Injectable CDMO Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Sterile Injectable CDMO Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Sterile Injectable CDMO Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Sterile Injectable CDMO Market Size Breakdown by Type (2021-2026)
3 Sterile Injectable CDMO Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Company
  3. 3.1.2 Research Institute
  4. 3.1.3 Other
  5. 3.2 Global Sterile Injectable CDMO Market Size by Application
  6. 3.2.1 Global Sterile Injectable CDMO Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Sterile Injectable CDMO Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Sterile Injectable CDMO Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Sterile Injectable CDMO Market Size by Regions
  10. 3.3.1 North America Sterile Injectable CDMO Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Sterile Injectable CDMO Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Sterile Injectable CDMO Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Sterile Injectable CDMO Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Sterile Injectable CDMO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Sterile Injectable CDMO Industry Trends
  2. 4.2 Sterile Injectable CDMO Industry Drivers
  3. 4.3 Sterile Injectable CDMO Industry Opportunities and Challenges
  4. 4.4 Sterile Injectable CDMO Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Sterile Injectable CDMO Revenue (2021-2026)
  2. 5.2 Global Sterile Injectable CDMO Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Sterile Injectable CDMO Key Company Headquarters & Area Served
  4. 5.4 Global Sterile Injectable CDMO Company, Product Type & Application
  5. 5.5 Global Sterile Injectable CDMO Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Sterile Injectable CDMO Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Sterile Injectable CDMO Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Sterile Injectable CDMO Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbvie
  2. 6.1.1 Abbvie Company Information
  3. 6.1.2 Abbvie Business Overview
  4. 6.1.3 Abbvie Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbvie Sterile Injectable CDMO Product Portfolio
  6. 6.1.5 Abbvie Recent Developments
  7. 6.2 Famar
  8. 6.2.1 Famar Company Information
  9. 6.2.2 Famar Business Overview
  10. 6.2.3 Famar Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Famar Sterile Injectable CDMO Product Portfolio
  12. 6.2.5 Famar Recent Developments
  13. 6.3 Polfa Tarchomin
  14. 6.3.1 Polfa Tarchomin Company Information
  15. 6.3.2 Polfa Tarchomin Business Overview
  16. 6.3.3 Polfa Tarchomin Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Polfa Tarchomin Sterile Injectable CDMO Product Portfolio
  18. 6.3.5 Polfa Tarchomin Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Sterile Injectable CDMO Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Quotient Sciences
  26. 6.5.1 Quotient Sciences Company Information
  27. 6.5.2 Quotient Sciences Business Overview
  28. 6.5.3 Quotient Sciences Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Quotient Sciences Sterile Injectable CDMO Product Portfolio
  30. 6.5.5 Quotient Sciences Recent Developments
  31. 6.6 Temad Co.
  32. 6.6.1 Temad Co. Company Information
  33. 6.6.2 Temad Co. Business Overview
  34. 6.6.3 Temad Co. Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Temad Co. Sterile Injectable CDMO Product Portfolio
  36. 6.6.5 Temad Co. Recent Developments
  37. 6.7 Tianjin Hankang Pharmaceutical Biotechnology
  38. 6.7.1 Tianjin Hankang Pharmaceutical Biotechnology Company Information
  39. 6.7.2 Tianjin Hankang Pharmaceutical Biotechnology Business Overview
  40. 6.7.3 Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Product Portfolio
  42. 6.7.5 Tianjin Hankang Pharmaceutical Biotechnology Recent Developments
  43. 6.8 Fareva
  44. 6.8.1 Fareva Company Information
  45. 6.8.2 Fareva Business Overview
  46. 6.8.3 Fareva Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Fareva Sterile Injectable CDMO Product Portfolio
  48. 6.8.5 Fareva Recent Developments
  49. 6.9 Sharp
  50. 6.9.1 Sharp Company Information
  51. 6.9.2 Sharp Business Overview
  52. 6.9.3 Sharp Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sharp Sterile Injectable CDMO Product Portfolio
  54. 6.9.5 Sharp Recent Developments
  55. 6.10 Astral SteriTech
  56. 6.10.1 Astral SteriTech Company Information
  57. 6.10.2 Astral SteriTech Business Overview
  58. 6.10.3 Astral SteriTech Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Astral SteriTech Sterile Injectable CDMO Product Portfolio
  60. 6.10.5 Astral SteriTech Recent Developments
  61. 6.11 Evonik
  62. 6.11.1 Evonik Company Information
  63. 6.11.2 Evonik Business Overview
  64. 6.11.3 Evonik Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Evonik Sterile Injectable CDMO Product Portfolio
  66. 6.11.5 Evonik Recent Developments
  67. 6.12 Aurigene Pharmaceutical Services
  68. 6.12.1 Aurigene Pharmaceutical Services Company Information
  69. 6.12.2 Aurigene Pharmaceutical Services Business Overview
  70. 6.12.3 Aurigene Pharmaceutical Services Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Aurigene Pharmaceutical Services Sterile Injectable CDMO Product Portfolio
  72. 6.12.5 Aurigene Pharmaceutical Services Recent Developments
  73. 6.13 Prague Scientific
  74. 6.13.1 Prague Scientific Company Information
  75. 6.13.2 Prague Scientific Business Overview
  76. 6.13.3 Prague Scientific Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Prague Scientific Sterile Injectable CDMO Product Portfolio
  78. 6.13.5 Prague Scientific Recent Developments
  79. 6.14 Ethypharm
  80. 6.14.1 Ethypharm Company Information
  81. 6.14.2 Ethypharm Business Overview
  82. 6.14.3 Ethypharm Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Ethypharm Sterile Injectable CDMO Product Portfolio
  84. 6.14.5 Ethypharm Recent Developments
  85. 6.15 TriRx Pharmaceutical Services
  86. 6.15.1 TriRx Pharmaceutical Services Company Information
  87. 6.15.2 TriRx Pharmaceutical Services Business Overview
  88. 6.15.3 TriRx Pharmaceutical Services Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 TriRx Pharmaceutical Services Sterile Injectable CDMO Product Portfolio
  90. 6.15.5 TriRx Pharmaceutical Services Recent Developments
  91. 6.16 Biophrama Group
  92. 6.16.1 Biophrama Group Company Information
  93. 6.16.2 Biophrama Group Business Overview
  94. 6.16.3 Biophrama Group Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Biophrama Group Sterile Injectable CDMO Product Portfolio
  96. 6.16.5 Biophrama Group Recent Developments
  97. 6.17 Gensenta Pharmaceuticals
  98. 6.17.1 Gensenta Pharmaceuticals Company Information
  99. 6.17.2 Gensenta Pharmaceuticals Business Overview
  100. 6.17.3 Gensenta Pharmaceuticals Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Gensenta Pharmaceuticals Sterile Injectable CDMO Product Portfolio
  102. 6.17.5 Gensenta Pharmaceuticals Recent Developments
  103. 6.18 BioTechnique
  104. 6.18.1 BioTechnique Company Information
  105. 6.18.2 BioTechnique Business Overview
  106. 6.18.3 BioTechnique Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 BioTechnique Sterile Injectable CDMO Product Portfolio
  108. 6.18.5 BioTechnique Recent Developments
  109. 6.19 Mithra CDMo
  110. 6.19.1 Mithra CDMo Company Information
  111. 6.19.2 Mithra CDMo Business Overview
  112. 6.19.3 Mithra CDMo Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Mithra CDMo Sterile Injectable CDMO Product Portfolio
  114. 6.19.5 Mithra CDMo Recent Developments
  115. 6.20 S.C. Rompharm Company SRL
  116. 6.20.1 S.C. Rompharm Company SRL Company Information
  117. 6.20.2 S.C. Rompharm Company SRL Business Overview
  118. 6.20.3 S.C. Rompharm Company SRL Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 S.C. Rompharm Company SRL Sterile Injectable CDMO Product Portfolio
  120. 6.20.5 S.C. Rompharm Company SRL Recent Developments
  121. 6.21 Flagship Biotech International Pvt. Ltd
  122. 6.21.1 Flagship Biotech International Pvt. Ltd Company Information
  123. 6.21.2 Flagship Biotech International Pvt. Ltd Business Overview
  124. 6.21.3 Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Product Portfolio
  126. 6.21.5 Flagship Biotech International Pvt. Ltd Recent Developments
  127. 6.22 Curida AS
  128. 6.22.1 Curida AS Company Information
  129. 6.22.2 Curida AS Business Overview
  130. 6.22.3 Curida AS Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Curida AS Sterile Injectable CDMO Product Portfolio
  132. 6.22.5 Curida AS Recent Developments
  133. 6.23 BirgiMefar Group
  134. 6.23.1 BirgiMefar Group Company Information
  135. 6.23.2 BirgiMefar Group Business Overview
  136. 6.23.3 BirgiMefar Group Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 BirgiMefar Group Sterile Injectable CDMO Product Portfolio
  138. 6.23.5 BirgiMefar Group Recent Developments
  139. 6.24 Brooks Laboratories Limited
  140. 6.24.1 Brooks Laboratories Limited Company Information
  141. 6.24.2 Brooks Laboratories Limited Business Overview
  142. 6.24.3 Brooks Laboratories Limited Sterile Injectable CDMO Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Brooks Laboratories Limited Sterile Injectable CDMO Product Portfolio
  144. 6.24.5 Brooks Laboratories Limited Recent Developments
7 North America
  1. 7.1 North America Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Sterile Injectable CDMO Market Size by Country (2021-2026)
  3. 7.3 North America Sterile Injectable CDMO Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Sterile Injectable CDMO Market Size by Country (2021-2026)
  3. 8.3 Europe Sterile Injectable CDMO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Sterile Injectable CDMO Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Sterile Injectable CDMO Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Sterile Injectable CDMO Market Size by Country (2021-2026)
  3. 10.3 South America Sterile Injectable CDMO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Sterile Injectable CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Sterile Injectable CDMO Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Sterile Injectable CDMO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst